Methylglyoxal

From WikiMD's WELLNESSPEDIA

Methylglyoxal (MGO) is a reactive dicarbonyl compound that is produced as a byproduct of several metabolic pathways. It is a highly reactive molecule and can react with proteins, nucleic acids, and lipids to form advanced glycation end products (AGEs). These reactions can lead to cellular damage and have been implicated in several diseases, including diabetes, cardiovascular disease, and neurodegenerative disorders.

Production and Metabolism[edit]

Methylglyoxal is produced in the body through several metabolic pathways. The primary source of MGO is from the degradation of glucose through the glycolytic pathway, specifically during the conversion of dihydroxyacetone phosphate (DHAP) to glyceraldehyde 3-phosphate (G3P). Other sources of MGO include the metabolism of amino acids, lipids, and the degradation of glycated proteins.

The body has several mechanisms to detoxify MGO and prevent its accumulation. The primary detoxification pathway is through the glyoxalase system, which consists of two enzymes, glyoxalase I and glyoxalase II. This system converts MGO to D-lactate, which is then further metabolized or excreted in the urine.

Role in Disease[edit]

Methylglyoxal has been implicated in several diseases, primarily through its ability to form advanced glycation end products (AGEs). These compounds can cause cellular damage and have been linked to a variety of diseases, including diabetes, cardiovascular disease, and neurodegenerative disorders.

In diabetes, high levels of glucose can lead to increased production of MGO, which can then react with proteins to form AGEs. These compounds can cause damage to various tissues and organs, contributing to the complications of diabetes.

Methylglyoxal has also been linked to cardiovascular disease. It can react with low-density lipoprotein (LDL), leading to the formation of glycated LDL, which is more prone to oxidation and can contribute to the development of atherosclerosis.

In neurodegenerative disorders, MGO can react with proteins in the brain to form AGEs, which can cause neuronal damage and contribute to the progression of diseases such as Alzheimer's and Parkinson's.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.